Insurance-covered medical cannabis reimbursements decline again in Germany Reports MJ Biz
Public health insurance reimbursements for cannabis in Germany have fallen for the second straight quarter.
Unless this drop is being offset by an increase in private prescriptions, it means that total sales of medical cannabis in Germany – Europe’s largest market – are decreasing. (Data for private prescriptions is not available.)
It is the first time reimbursements have fallen for two consecutive quarters since the medical program started in early 2017, according to new data for the period ended Sept. 30.
Read the full reports and see charts at